 I. To demonstrate the safety and feasibility of rHIV7-shI-TAR-CCR5RZ-treated hematopoietic stem progenitor cells HSPC lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells transplantation in AIDS patients completing treatment for non-Hodgkin lymphoma NHL. 